Hugel Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Ji-hoon Sohn

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	6.3yrs
CEO ownership	n/a
Management average tenure	6.3yrs
Board average tenure	2.1yrs

Recent management updates

Recent updates

Are Hugel, Inc.'s (KOSDAQ:145020) Mixed Financials Driving The Negative Sentiment?

Mar 19

What Is The Ownership Structure Like For Hugel, Inc. (KOSDAQ:145020)?

Feb 25

Does Hugel (KOSDAQ:145020) Have A Healthy Balance Sheet?

Feb 04

The Hugel (KOSDAQ:145020) Share Price Has Gained 197%, So Why Not Pay It Some Attention?

Jan 17

Does Hugel's (KOSDAQ:145020) Statutory Profit Adequately Reflect Its Underlying Profit?

Dec 29

Does This Valuation Of Hugel, Inc. (KOSDAQ:145020) Imply Investors Are Overpaying?

Dec 14

How Many Hugel, Inc. (KOSDAQ:145020) Shares Do Institutions Own?

Nov 24

CEO

Ji-hoon Sohn

6.3yrs

Tenure

Mr. Ji-hoon Sohn has been Chief Executive Officer of Hugel, Inc. since 2018. He served as Co-Chair of the Board of Directors at Hugel, Inc. and serves as its Director since March 2018. He served as Chief E...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Ji-hoon Sohn	CEO & Executive Director	6.3yrs	no data	no data
J. T. Kim	MD & CFO	5.3yrs	no data	no data
Seonho Han	VP and Chief Sales & Marketing Officer	6.3yrs	no data	no data
Soon-Woo Kwon	VP & Chief Production Officer	13.3yrs	no data	no data
Jennifer Rho	MD & Chief Strategy Officer	no data	no data	no data
Minjong Kang	MD & Head of Marketing	5.3yrs	no data	no data
Jihye Song	MD & Head of Cosmetics	6.3yrs	no data	no data
Young Mahn Yoo	MD & Chief Production Officer	no data	no data	no data

6.3yrs

Average Tenure

Experienced Management: A145020's management team is seasoned and experienced (6.3 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Ji-hoon Sohn	CEO & Executive Director	6.2yrs	no data	no data
Brenton L. Saunders	Non-Executive Chairman of the Board of Directors & Chair of Advisory Board	2yrs	no data	no data
Michael Keyoung	Non-Executive Director	2.1yrs	no data	no data
Patrick Holt	Independent Director	2.1yrs	no data	no data
Suh Hur	Non-Executive Director	2.1yrs	no data	no data
Tae Hyoung Lee	Non-Executive Director	2.1yrs	no data	no data
Seungmin Chee	Independent Director	2.1yrs	no data	no data
Suk-yong Cha	Non-Executive Director	1.2yrs	no data	no data

2.1yrs

Average Tenure

50.5yo

Average Age

Experienced Board: A145020's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.

Hugel Management

Management criteria checks 1/4

Key information

Recent management updates

Less than half of directors are independent

Hugel, Inc. Appoints Brent Saunders to its Board of Director

No independent directors

Hugel, Inc., Annual General Meeting, Mar 26, 2021

Recent updates

Now 22% undervalued

Hugel, Inc. to Report Q1, 2024 Final Results on May 09, 2024

Hugel (KOSDAQ:145020) Seems To Use Debt Rather Sparingly

Hugel's (KOSDAQ:145020) Performance Is Even Better Than Its Earnings Suggest

Hugel, Inc. (KOSDAQ:A145020) announces an Equity Buyback for KRW 50,000 million worth of its shares.

Now 23% undervalued

Hugel, Inc.'s (KOSDAQ:145020) 25% Price Boost Is Out Of Tune With Earnings

Calculating The Fair Value Of Hugel, Inc. (KOSDAQ:145020)

Investor sentiment improves as stock rises 19%

Price target increased by 8.7% to ₩201,750

Hugel, Inc. (KOSDAQ:A145020) announces an Equity Buyback for KRW 50,000 million worth of its shares.

Consensus EPS estimates increase by 38%

Price target increased by 8.1% to ₩172,571

Hugel Resubmits BLA for Its Botulinum Toxin, Letybo to the U.S. Fda

Price target decreased by 8.8% to ₩159,250

Hugel, Inc. (KOSDAQ:A145020) acquired additional 3.13% stake in Across Co., Ltd for KRW 9.385 billion.

Investor sentiment deteriorates as stock falls 18%

Price target increased by 7.3% to ₩189,714

Investor sentiment deteriorates as stock falls 18%

Hugel, Inc. (KOSDAQ:A145020) announces an Equity Buyback for KRW 50,000 million worth of its shares.

Now 29% undervalued

Now 20% undervalued

Investor sentiment improved over the past week

Hugel's 'Letybo' First in Korea to Obtain Marketing Approval from Australia

Less than half of directors are independent

Consensus forecasts updated

Investor sentiment improved over the past week

Price target decreased to ₩194,875

Hugel, Inc. Appoints Brent Saunders to its Board of Director

No independent directors

Hugel, Inc. (KOSDAQ:A145020) announces an Equity Buyback for KRW 50,000 million worth of its shares.

Price target decreased to ₩214,889

Investor sentiment deteriorated over the past week

Price target decreased to ₩238,333

Consensus EPS estimates fall by 10%

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Are Hugel, Inc.'s (KOSDAQ:145020) Mixed Financials Driving The Negative Sentiment?

What Is The Ownership Structure Like For Hugel, Inc. (KOSDAQ:145020)?

New 90-day low: ₩174,400

Hugel, Inc. Announces Approval to Launch of Letybo 50U in Prc Market

Hugel, Inc., Annual General Meeting, Mar 26, 2021

Does Hugel (KOSDAQ:145020) Have A Healthy Balance Sheet?

Hugel, Inc. to Report Fiscal Year 2020 Results on Feb 09, 2021

Investor sentiment improved over the past week

New 90-day high: ₩224,700

The Hugel (KOSDAQ:145020) Share Price Has Gained 197%, So Why Not Pay It Some Attention?

Price target raised to ₩251,818

Does Hugel's (KOSDAQ:145020) Statutory Profit Adequately Reflect Its Underlying Profit?

Does This Valuation Of Hugel, Inc. (KOSDAQ:145020) Imply Investors Are Overpaying?

New 90-day low: ₩175,600

How Many Hugel, Inc. (KOSDAQ:145020) Shares Do Institutions Own?

Price target raised to ₩241,515

Price target raised to ₩227,788

Price target raised to ₩211,861

Market bids up stock over the past week

New 90-day high: ₩219,900

New 90-day high - ₩194,600

Hugel, Inc. to Report First Half, 2020 Results on Aug 11, 2020

CEO

Tenure

Leadership Team

Average Tenure

Board Members

Average Tenure

Average Age